insurance changes glp-1 change impacts millions of Americans: What to know, how to tell if you're covered Insurance coverage just changed for

Latest GLP-1 Study 2025: Key Findings Everyone Is Talking About The latest GLP-1 study 2025 (ATTAIN-1) shows that orforglipron led to meaningful weight loss, better metabolic control, and improvements in heart-related markers

"And they said: 'Look, we're pulling this medication

Rybelsus (semaglutide tablets): transition to new formulation and risk of medication error

MariTide gives Amgen a different route into the market

For Foundayo, the most frequently reported side effects were mild to moderate and also gastrointestinal in nature, including nausea, constipation, diarrhea, vomiting, indigestion and stomach pain

The key is being patient with the process and working closely with your healthcare team